Methyl 4-(4-hydroxypiperidin-4-yl)benzoate hydrochloride, 97%, 1g

4-Amino-n,2-dimethylbenzene-1-sulfonamide, 95%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-aminobutanoic acid, 95.0%, 5g

2-Bromo-4,6-dimethyl-nicotinonitrile, 98%, 250mg

1-Thiazol-5-yl-ethanone, 96.0%, 1g

3-(1,3-Benzodioxol-5-yl)-1-phenyl-2-propen-1-one>98.0%(GC)1g

3-(2-Pyridyl)-D-alanine, >98%, 25g

(2-Bromobenzo[d]thiazol-6-yl)methanol, 95%, 250mg

4-FLUORO-2-(DIFLUOROMETHYL)ANISOLE, 95.0%, 1g

Récipients de réactifs Contenu 100 ml, stériles, individuels, 50 pièces, 50 pièces

[4-(butyrylamino)phenyl]acetic acid, 95.0%, 5g

4-((3,4-DIMETHYLPHENYL)AMINO)-7-(PYRIDIN-4-YL)QUINOLINE-3-CARBOXAMIDE, 95%, 1mg

5-Methoxypyrazine-2-carbaldehyde, 97%, 5g